论文信息 - Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells. - 字舞流文

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

C. Sotiriou | S. Loi | S. Michiels | H. Joensuu | P. Kellokumpu-Lehtinen | M. Smyth | D. Mittal | F. Caramia